Tag Archives: Actelion

September, 2018

June, 2017

January, 2017

  • 30 January

    Johnson & Johnson to Acquire Actelion in $30 Billion Deal

    NEW BRUNSWICK, N.J. and ALLSCHWIL and BASEL, Switzerland, Jan. 26, 2017 /PRNewswire/ — Johnson & Johnson (NYSE: JNJ) and Actelion Ltd. (SIX:ATLN) today announced that they have entered into a definitive transaction agreement under which Johnson & Johnson will launch an all-cash tender offer in Switzerland to acquire all of …

December, 2016

November, 2016

  • 28 November

    J&J Approaches Actelion Regarding Potential Takeover Deal

    ALLSCHWIL, SWITZERLAND – 25 November 2016 – Actelion (SIX: ATLN) confirmed today that it has been approached by Johnson & Johnson about a possible transaction. There can be no certainty that a transaction will result. ### ACTELION LTD Actelion Ltd. is a leading biopharmaceutical company focused on the discovery, development …

December, 2015

  • 28 December

    FDA Approves Actelion’s Uptravi for Pulmonary Arterial Hypertension

    ALLSCHWIL, SWITZERLAND – 22 December 2015 – Actelion (SIX: ATLN) announced today that the United States Food and Drug Administration (FDA) has approved the use of the orally active, selective IP prostacyclin receptor agonist Uptravi (selexipag), originally discovered and synthesized by Nippon Shinyaku, for the treatment of pulmonary arterial hypertension …